STANFORD UNIVERSITY

Stanford Medicine’s Spectrum receives $70M NIH grant to accelerate biomedical treatment translation, led by Ruth O’Hara, aiming to improve patient care and population health. The grant, spanning until 2031, supports collaborative research with Kaiser Permanente and the University of Hawaii, and training for future investigators.

Surbhi Sidana discusses minimal residual disease (MRD) in multiple myeloma, explaining its role in detecting undetectable disease remnants post-treatment, influencing future treatment decisions, and its potential as a surrogate end point for drug approval.

Nicholas Bloom of Stanford University presents 'Hybrid Working From Home Improves Retention Without Damaging Performance' at PCT Grand Rounds on October 25, 2024, 1:00 pm eastern.

SeaStar Medical Holding Corporation announces Stanford Medicine's clearance to enroll subjects in the NEUTRALIZE-AKI pivotal trial, evaluating the Selective Cytopheretic Device (SCD) for acute kidney injury (AKI). The trial aims to assess SCD's safety and efficacy in reducing hyperinflammation, with 12 sites now activated for enrollment.

SeaStar Medical announces Stanford Medicine's clearance to enroll subjects in the NEUTRALIZE-AKI pivotal trial for their Selective Cytopheretic Device (SCD), with 12 active sites and 52 enrolled subjects, aiming to enroll up to 200 adults with acute kidney injury (AKI) in ICU receiving continuous kidney replacement therapy (CKRT), focusing on 90-day mortality or dialysis dependency.

At AAO 2024, NT-501 CNTF-secreting implants for glaucoma showed safety, stable IOP, and increased retinal nerve fibre layer thickness, suggesting neuroprotection potential.

The 16th Frontiers in Cancer Science (FCS) conference will be held in Singapore from November 13-15, 2024, featuring international and regional speakers on topics like immuno-oncology, genomics, metabolism, and AI. Young investigators can present their work, with prizes including travel awards to the AACR Annual Meeting 2025. The conference is jointly organized by several Singaporean institutions and has partnered with the American Association for Cancer Research (AACR) since 2020.

Nicholas Bloom of Stanford University presents 'Hybrid Working From Home Improves Retention Without Damaging Performance' at PCT Grand Rounds on October 25, 2024, at 1:00 pm eastern.

HudsonAlpha Institute for Biotechnology appoints Dr. Florencia Behn as Vice President for Research Administration and Development, effective November 1, 2024. Behn will lead research administration, oversee policies, and collaborate with Chief Scientific Officer Dr. Rick Myers. Starting in 2025, she will also manage Strategic Software and Greenhouse teams, and continue to oversee research communications and the Trainee Program.

Nanoscope Therapeutics announces breakthrough discovery in TVST demonstrating MCO-010 optogenetic treatment halts retinal degeneration in RP animal model, with plans for BLA submission for RP treatment in Q1 2025.